O'Shaughnessy Asset Management, LLC Veracyte, Inc. Transaction History

O'Shaughnessy Asset Management, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$36.09 - $53.79 $6,676 - $9,951	-185 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$35.62 - $52.97 $140,520 - $208,966	-3,945 Reduced 95.52%	185 $9,000
Q2 2021 Aug 09, 2021	SELL	$32.94 - $56.62 $145,265 - $249,694	-4,410 Reduced 51.64%	4,130 $165,000
Q1 2021 May 14, 2021	BUY	$44.47 - $81.38 $11,384 - $20,833	256 Added 3.09%	8,540 $459,000
Q4 2020 Feb 11, 2021	BUY	$32.49 - $61.88 $269,147 - $512,613	8,284 New	8,284 $405,000

308

81.8M

134K

13.3K

Ticker VCYT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,575,904
Market Cap $3.07B
Description
Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...

Get notified when there are updates to the investment portfolio of O'Shaughnessy Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on O'Shaughnessy Asset Management, LLC with notifications on news.